Aflibercept in macular oedema: Added benefit not proven

Tuesday, January 7, 2014 - 16:00 in Health & Medicine

Due to a lack of suitable data, it is not proven that visual impairment in macular oedema can be treated more effectively with aflibercept than with the appropriate comparator therapy.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net